

Accelerating and automating chemical synthesis removes a major bottleneck in drug development, lowering costs and enabling faster testing of novel compounds, which could reshape R&D pipelines for pharma and biotech and reduce reliance on overseas contract labs.
Comments
Want to join the conversation?
Loading comments...